Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Non-Current Assets (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Non-Current Assets came in at $18.3 billion in Q2 2026, down 11.95% year-over-year from $20.8 billion in Q2 2025, and down 1.34% quarter-over-quarter from $18.5 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Non-Current Assets (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Non-Current Assets across 18 years of filings, most recently posting $18.3 billion for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 11.95% year-over-year to $18.3 billion; the TTM figure through Jun 2026 stood at $77.6 billion (down 6.96% YoY), while the FY2025 annual figure was $20.2 billion, down 2.6% from the prior year.
  • Non-Current Assets came in at $18.3 billion for Q2 2026 at Bausch Health Companies, down from $18.5 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $23.3 billion in Q1 2022 to a low of $18.3 billion in Q2 2026.
  • Average Non-Current Assets over 5 years is $21.1 billion, with a median of $21.2 billion recorded in 2023.
  • Year-over-year, Non-Current Assets grew 1.47% in 2023 and decreased 11.95% in 2026.
  • Over 5 years, Non-Current Assets stood at $21.4 billion in 2022, then rose by 1.47% to $21.8 billion in 2023, then declined by 4.62% to $20.7 billion in 2024, then retreated by 2.6% to $20.2 billion in 2025, then dropped by 9.58% to $18.3 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $18.3 billion in Q2 2026, $18.5 billion in Q1 2026, and $20.2 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 26.10 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 24.99 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 2.92 Bn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 1.83 Bn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 18.27 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 1.04 Bn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 668.68 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 1.11 Bn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn 3.25 Mn
10 RedHill Biopharma 171.02 Mn 171.02 Mn - 18.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.27 Bn
Mar 31, 2026 18.52 Bn
Dec 31, 2025 20.21 Bn
Sep 30, 2025 20.58 Bn
Jun 30, 2025 20.75 Bn
Mar 31, 2025 20.69 Bn
Dec 31, 2024 20.75 Bn
Sep 30, 2024 21.19 Bn
Jun 30, 2024 21.28 Bn
Mar 31, 2024 21.52 Bn
Dec 31, 2023 21.75 Bn
Sep 30, 2023 22.02 Bn
Jun 30, 2023 21.04 Bn
Mar 31, 2023 21.21 Bn
Dec 31, 2022 21.44 Bn
Sep 30, 2022 22.29 Bn
Jun 30, 2022 22.75 Bn
Mar 31, 2022 23.25 Bn
Dec 31, 2021 23.60 Bn
Sep 30, 2021 23.93 Bn